Intelligence Platform
Patents
Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10087211
Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore m
granted patentUS 10087148
Quinazolines as biogenic amine transport modulators
granted patentUS 10086061
Combination purified inactivated vaccine for flaviviruses
granted patentUS 10077296
Methods and compositions for the treatment and prevention of cancer
granted patentUS 10076535
Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing
granted patentUS 10072078
M971 chimeric antigen receptors
granted patentUS 10072070
Potent anti-influenza A neuraminidase subtype N1 antibody
granted patentUS 10071945
Nuclear receptor modulators and their use for the treatment and prevention of cancer
granted patentUS 10058602
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine
granted patentUS 10058559
Treatment or prevention of an intestinal disease or disorder
granted patentUS 10053503
Monoclonal antibodies that neutralize anthrax toxins
granted patentUS 10052369
Aquaporin 2 protects cattle from ticks and tick-borne parasites
granted patentUS 10051880
Hydroxybutyrate ester and medical use thereof
granted patentUS 10047401
Expression protein-coding and noncoding genes as prognostic classifiers in early stage lun
granted patentUS 10047148
Neutralizing GP41 antibodies and their use
granted patentUS 10047147
Neutralizing GP41 antibodies and their use
granted patentUS 10047122
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and
granted patentUS 10046012
Multipotent postnatal stem cells from human periodontal ligament and uses thereof
granted patentUS 10039819
Attenuated Mannheimia haemolytica strains
granted patentUS 10039818
Attenuated pasteurella multocida strains
granted patentUS 10036020
Compositions and methods for inhibiting JC virus (JCV)
granted patentUS 10035848
Antibody targeting cell surface deposited complement protein C3d and use thereof
granted patentUS 10035845
Neutralizing antibodies to HIV-1 and their use
granted patentUS 10035844
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envel
granted